Media Contact:Karla Schuster
Send an E-mail
Date: Jan 10, 2011
Steven Freiberg, CEO of E*TRADE; Colin Goddard, Former CEO of OSI Pharmaceuticals, appointed to Hofstra Board of Trustees
Freiberg, Hofstra ’79, ‘80, and Goddard, former commencement speaker, join Hofstra’s governing panel
Hofstra University, Hempstead, NY - Steven Freiberg, chief executive officer of E*TRADE, and Dr. Colin Goddard, Ph.D, former chief executive officer and director of OSI Pharmaceuticals, have been appointed to the university's Board of Trustees, President Stuart Rabinowitz announced today.
Freiberg, an alumnus who earned his bachelor's and master's degrees from the Frank G. Zarb School of Business, has been honored with the Alumni Achievement Award and recently endowed a scholarship at the Zarb School. Goddard, a noted cancer pharmacologist, has been a distinguished lecturer, an honorary degree recipient and commencement speaker.
"Both of these men have enduring ties to Hofstra," President Rabinowitz said. "Steven Freiberg is an alumnus who personifies Hofstra pride and purpose, not just in his professional accomplishments, but in his personal generosity to this institution. "Dr. Colin Goddard -- and under his leadership, OSI Pharmaceuticals -- have long been committed to a variety of programs and events at Hofstra, with a particular commitment to promoting science education. It's my great pleasure to welcome them to the Board of Trustees."
Freiberg, with a bachelor's degree in banking and finance and a master's of business administration from the Zarb School, became CEO of E*TRADE, the financial services company primarily known as an online stock brokerage service, in April 2010. He also spent three decades in various executive positions with Citigroup, Co-Chairman and CEO of the Global Consumer Group, Chairman and CEO of Citicards and Chairman and CEO of Citicorp Investment Services Group.
He has served on the boards of Citibank N.A., Citicorp Credit Services, Inc., Citicorp Investment Services, Citicorp Insurance Group, Citibank Trust N.A., Citibank FSB, the Direct Marketing Association and the Financial Services Roundtable. He is now serving as a member of the boards of MasterCard International, E*Trade Financial Corporation, the March of Dimes and is co-chair of the New York City Council for Habitat for Humanity.
In 2010, he and his wife, Neena, a 1981 alumna, established the Steven and Neena Freiberg Endowed Scholarship. He is also included on the William and Kate Hofstra Honor Roll, a roster created in honor of the university's 75th anniversary that recognizes individuals who have had a lasting impact on the institution. He and his wife live in Jericho.
Dr. Colin Goddard, Ph.D., was CEO and director of the Melville-based OSI Pharmaceuticals from 1998 until its acquisition by the Japanese pharmaceutical company Astellas in 2010. He began his career there in 1989 as a scientist, and served as director of drug discovery and pharmaceutical operations, vice president of research operations, executive vice president and chief operating officer, and president. He led the approval and launch of OSI's flagship product, the cancer drug Tarceva®, and shepherded OSI from its transition from technology platform services to an integrated biopharmaceutical organization.
An active member of several organizations that promote advancement of cancer treatment, science education and the biotech industry, Dr. Goddard serves on the board of directors of Human Genome Sciences, Inc. Zelos Therapeutics, Inc. and Abilities! He is a former chair of the New York Biotechnology Association and member of the boards of the Biotechnology Industry Association, PhRMA and the CEO Roundtable on Cancer, and he is a member of the American Association of Cancer Research.
In 2007, Dr. Goddard was the keynote speaker for Hofstra's Distinguished Lecture Series, delivering a presentation called "Are we winning the war on cancer?" In 2005, he received an honorary degree and was Hofstra's mid-year commencement speaker. He earned his Ph.D., from the University of Aston, Birmingham, U.K. in 1985.
Hofstra University is a dynamic private institution where students can choose from about 150 undergraduate and more than 160 graduate programs in liberal arts and sciences, business; engineering; communication; education, health and human services; and honors studies, as well as a School of Law. The University also provides excellent facilities with state-of-the-art technology, extensive library resources and internship programs that match students' interests and abilities with appropriate companies and organizations. The Hofstra community is driven, dynamic and energetic, helping students find and focus their strengths to prepare them for a successful future.